Autolus Therapeutics to Announce Q3 2024 Financial Results on November 12

Autolus Therapeutics plc (NASDAQ: AUTL), a leader in developing advanced T cell therapies, will announce its third quarter 2024 financial results and operational updates on November 12, 2024, prior to the opening of US markets. A conference call and webcast will be held at 8:30 am EDT/1:30 pm BST to discuss the financial outcomes and business developments. Interested participants are encouraged to pre-register to obtain the necessary access details for the call. The webcast and its replay will be available in the events section of Autolus' official website.